IL267047B2 - Catheters, systems and related methods for mapping, minimizing and treating cardiac fibrillation - Google Patents
Catheters, systems and related methods for mapping, minimizing and treating cardiac fibrillationInfo
- Publication number
- IL267047B2 IL267047B2 IL267047A IL26704719A IL267047B2 IL 267047 B2 IL267047 B2 IL 267047B2 IL 267047 A IL267047 A IL 267047A IL 26704719 A IL26704719 A IL 26704719A IL 267047 B2 IL267047 B2 IL 267047B2
- Authority
- IL
- Israel
- Prior art keywords
- tissue
- electrode
- ablation
- electrodes
- electrogram
- Prior art date
Links
- 238000000034 method Methods 0.000 title description 134
- 206010061592 cardiac fibrillation Diseases 0.000 title description 90
- 238000013507 mapping Methods 0.000 title description 79
- 210000001519 tissue Anatomy 0.000 claims description 691
- 239000000758 substrate Substances 0.000 claims description 81
- 210000005003 heart tissue Anatomy 0.000 claims description 36
- 230000008859 change Effects 0.000 claims description 25
- 230000000747 cardiac effect Effects 0.000 claims description 14
- 230000004044 response Effects 0.000 claims description 7
- 238000002679 ablation Methods 0.000 description 242
- 230000004913 activation Effects 0.000 description 152
- 238000001994 activation Methods 0.000 description 152
- 210000004027 cell Anatomy 0.000 description 141
- 238000002565 electrocardiography Methods 0.000 description 137
- 206010003658 Atrial Fibrillation Diseases 0.000 description 133
- 230000003902 lesion Effects 0.000 description 117
- 230000001965 increasing effect Effects 0.000 description 77
- 230000006870 function Effects 0.000 description 73
- 230000000694 effects Effects 0.000 description 70
- 230000005284 excitation Effects 0.000 description 69
- 210000002216 heart Anatomy 0.000 description 64
- 238000009826 distribution Methods 0.000 description 61
- 238000005194 fractionation Methods 0.000 description 53
- 230000002600 fibrillogenic effect Effects 0.000 description 46
- 238000005259 measurement Methods 0.000 description 45
- 230000001746 atrial effect Effects 0.000 description 44
- 230000008569 process Effects 0.000 description 41
- 239000000243 solution Substances 0.000 description 38
- 230000036982 action potential Effects 0.000 description 37
- 230000007423 decrease Effects 0.000 description 35
- 238000004458 analytical method Methods 0.000 description 31
- 230000033764 rhythmic process Effects 0.000 description 29
- 231100000241 scar Toxicity 0.000 description 29
- 238000013459 approach Methods 0.000 description 28
- 230000005684 electric field Effects 0.000 description 28
- 238000012545 processing Methods 0.000 description 28
- 206010003119 arrhythmia Diseases 0.000 description 27
- 238000005094 computer simulation Methods 0.000 description 27
- 230000006793 arrhythmia Effects 0.000 description 25
- 230000003247 decreasing effect Effects 0.000 description 24
- 210000004379 membrane Anatomy 0.000 description 24
- 238000003491 array Methods 0.000 description 23
- 238000011282 treatment Methods 0.000 description 23
- 239000012528 membrane Substances 0.000 description 22
- 230000002123 temporal effect Effects 0.000 description 22
- 230000008901 benefit Effects 0.000 description 21
- 230000001976 improved effect Effects 0.000 description 21
- 238000004422 calculation algorithm Methods 0.000 description 19
- 238000002474 experimental method Methods 0.000 description 18
- 230000002829 reductive effect Effects 0.000 description 18
- 238000013153 catheter ablation Methods 0.000 description 17
- 208000032544 Cicatrix Diseases 0.000 description 15
- 238000003384 imaging method Methods 0.000 description 15
- 230000037387 scars Effects 0.000 description 15
- 238000004088 simulation Methods 0.000 description 15
- 210000002837 heart atrium Anatomy 0.000 description 14
- 230000006399 behavior Effects 0.000 description 13
- 238000005457 optimization Methods 0.000 description 13
- 238000001228 spectrum Methods 0.000 description 13
- 238000012360 testing method Methods 0.000 description 13
- 210000004369 blood Anatomy 0.000 description 12
- 239000008280 blood Substances 0.000 description 12
- 210000002064 heart cell Anatomy 0.000 description 12
- 210000005246 left atrium Anatomy 0.000 description 12
- 230000036279 refractory period Effects 0.000 description 12
- 238000013461 design Methods 0.000 description 11
- 210000003492 pulmonary vein Anatomy 0.000 description 11
- 239000003416 antiarrhythmic agent Substances 0.000 description 10
- 230000001413 cellular effect Effects 0.000 description 10
- 230000002068 genetic effect Effects 0.000 description 10
- 238000005070 sampling Methods 0.000 description 10
- 230000015572 biosynthetic process Effects 0.000 description 9
- 230000000875 corresponding effect Effects 0.000 description 9
- 230000001419 dependent effect Effects 0.000 description 9
- 238000010586 diagram Methods 0.000 description 9
- 230000005923 long-lasting effect Effects 0.000 description 9
- 230000007246 mechanism Effects 0.000 description 9
- 230000028161 membrane depolarization Effects 0.000 description 9
- 230000008093 supporting effect Effects 0.000 description 9
- 238000004364 calculation method Methods 0.000 description 8
- 230000000638 stimulation Effects 0.000 description 8
- 238000011298 ablation treatment Methods 0.000 description 7
- 238000005516 engineering process Methods 0.000 description 7
- 230000006872 improvement Effects 0.000 description 7
- 239000013598 vector Substances 0.000 description 7
- 239000003814 drug Substances 0.000 description 6
- 229940079593 drug Drugs 0.000 description 6
- 238000002001 electrophysiology Methods 0.000 description 6
- 230000007831 electrophysiology Effects 0.000 description 6
- 230000002332 fibrillatory effect Effects 0.000 description 6
- 238000001727 in vivo Methods 0.000 description 6
- 230000004807 localization Effects 0.000 description 6
- 239000000523 sample Substances 0.000 description 6
- 102000004310 Ion Channels Human genes 0.000 description 5
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 5
- 241000282898 Sus scrofa Species 0.000 description 5
- 230000003288 anthiarrhythmic effect Effects 0.000 description 5
- 206010003668 atrial tachycardia Diseases 0.000 description 5
- 230000002457 bidirectional effect Effects 0.000 description 5
- 238000001514 detection method Methods 0.000 description 5
- 239000000835 fiber Substances 0.000 description 5
- 210000003976 gap junction Anatomy 0.000 description 5
- 230000002045 lasting effect Effects 0.000 description 5
- 239000011159 matrix material Substances 0.000 description 5
- 230000000306 recurrent effect Effects 0.000 description 5
- 238000000926 separation method Methods 0.000 description 5
- 238000002604 ultrasonography Methods 0.000 description 5
- 230000002861 ventricular Effects 0.000 description 5
- 239000004020 conductor Substances 0.000 description 4
- 230000002596 correlated effect Effects 0.000 description 4
- 230000002999 depolarising effect Effects 0.000 description 4
- 229910003460 diamond Inorganic materials 0.000 description 4
- 239000010432 diamond Substances 0.000 description 4
- 230000003292 diminished effect Effects 0.000 description 4
- 238000010494 dissociation reaction Methods 0.000 description 4
- 230000005593 dissociations Effects 0.000 description 4
- 210000001174 endocardium Anatomy 0.000 description 4
- 238000000126 in silico method Methods 0.000 description 4
- 230000006698 induction Effects 0.000 description 4
- 238000002955 isolation Methods 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 238000002483 medication Methods 0.000 description 4
- 238000012544 monitoring process Methods 0.000 description 4
- 238000000491 multivariate analysis Methods 0.000 description 4
- 230000037361 pathway Effects 0.000 description 4
- 230000009467 reduction Effects 0.000 description 4
- 210000005247 right atrial appendage Anatomy 0.000 description 4
- 210000005245 right atrium Anatomy 0.000 description 4
- 230000035945 sensitivity Effects 0.000 description 4
- 238000001356 surgical procedure Methods 0.000 description 4
- 230000001052 transient effect Effects 0.000 description 4
- 208000003663 ventricular fibrillation Diseases 0.000 description 4
- 206010047302 ventricular tachycardia Diseases 0.000 description 4
- 238000010989 Bland-Altman Methods 0.000 description 3
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 3
- 230000002159 abnormal effect Effects 0.000 description 3
- 210000001367 artery Anatomy 0.000 description 3
- 238000013194 cardioversion Methods 0.000 description 3
- 210000000170 cell membrane Anatomy 0.000 description 3
- 238000002591 computed tomography Methods 0.000 description 3
- 239000002872 contrast media Substances 0.000 description 3
- 229910052802 copper Inorganic materials 0.000 description 3
- 239000010949 copper Substances 0.000 description 3
- 210000003748 coronary sinus Anatomy 0.000 description 3
- 230000003205 diastolic effect Effects 0.000 description 3
- 230000003467 diminishing effect Effects 0.000 description 3
- 238000004070 electrodeposition Methods 0.000 description 3
- 230000007717 exclusion Effects 0.000 description 3
- 230000000977 initiatory effect Effects 0.000 description 3
- 230000003993 interaction Effects 0.000 description 3
- 210000005248 left atrial appendage Anatomy 0.000 description 3
- 238000002595 magnetic resonance imaging Methods 0.000 description 3
- 230000035772 mutation Effects 0.000 description 3
- 210000004165 myocardium Anatomy 0.000 description 3
- 230000002085 persistent effect Effects 0.000 description 3
- 230000000750 progressive effect Effects 0.000 description 3
- 239000011780 sodium chloride Substances 0.000 description 3
- 230000003068 static effect Effects 0.000 description 3
- 238000012549 training Methods 0.000 description 3
- 230000009466 transformation Effects 0.000 description 3
- 238000012800 visualization Methods 0.000 description 3
- 206010001497 Agitation Diseases 0.000 description 2
- 208000032845 Atrial Remodeling Diseases 0.000 description 2
- 206010003662 Atrial flutter Diseases 0.000 description 2
- 241000282412 Homo Species 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 238000000692 Student's t-test Methods 0.000 description 2
- 230000001668 ameliorated effect Effects 0.000 description 2
- 230000003321 amplification Effects 0.000 description 2
- 230000003542 behavioural effect Effects 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 239000000470 constituent Substances 0.000 description 2
- 238000013211 curve analysis Methods 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 238000002059 diagnostic imaging Methods 0.000 description 2
- 230000004069 differentiation Effects 0.000 description 2
- 230000010339 dilation Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 230000008030 elimination Effects 0.000 description 2
- 238000003379 elimination reaction Methods 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 230000001747 exhibiting effect Effects 0.000 description 2
- 210000003128 head Anatomy 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 238000011835 investigation Methods 0.000 description 2
- 230000001788 irregular Effects 0.000 description 2
- 210000005240 left ventricle Anatomy 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 238000012423 maintenance Methods 0.000 description 2
- 210000004115 mitral valve Anatomy 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 230000002107 myocardial effect Effects 0.000 description 2
- 238000003199 nucleic acid amplification method Methods 0.000 description 2
- 230000003287 optical effect Effects 0.000 description 2
- 210000003516 pericardium Anatomy 0.000 description 2
- 230000000737 periodic effect Effects 0.000 description 2
- 230000035479 physiological effects, processes and functions Effects 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 230000001902 propagating effect Effects 0.000 description 2
- 238000009877 rendering Methods 0.000 description 2
- 230000003252 repetitive effect Effects 0.000 description 2
- 230000000284 resting effect Effects 0.000 description 2
- 230000036390 resting membrane potential Effects 0.000 description 2
- 230000002441 reversible effect Effects 0.000 description 2
- 210000005241 right ventricle Anatomy 0.000 description 2
- 125000006850 spacer group Chemical group 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 238000003325 tomography Methods 0.000 description 2
- 210000000591 tricuspid valve Anatomy 0.000 description 2
- 210000003462 vein Anatomy 0.000 description 2
- 210000001631 vena cava inferior Anatomy 0.000 description 2
- 210000002620 vena cava superior Anatomy 0.000 description 2
- 206010000060 Abdominal distension Diseases 0.000 description 1
- 208000034053 Accessory Atrioventricular Bundle Diseases 0.000 description 1
- 206010002091 Anaesthesia Diseases 0.000 description 1
- 206010003130 Arrhythmia supraventricular Diseases 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 241000282465 Canis Species 0.000 description 1
- 206010058039 Cardiac perforation Diseases 0.000 description 1
- 208000006687 Esophageal Fistula Diseases 0.000 description 1
- 238000000729 Fisher's exact test Methods 0.000 description 1
- 206010019280 Heart failures Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- PIWKPBJCKXDKJR-UHFFFAOYSA-N Isoflurane Chemical compound FC(F)OC(Cl)C(F)(F)F PIWKPBJCKXDKJR-UHFFFAOYSA-N 0.000 description 1
- 206010028347 Muscle twitching Diseases 0.000 description 1
- 206010065835 Oesophageal fistula Diseases 0.000 description 1
- 229920005372 Plexiglas® Polymers 0.000 description 1
- NPYPAHLBTDXSSS-UHFFFAOYSA-N Potassium ion Chemical compound [K+] NPYPAHLBTDXSSS-UHFFFAOYSA-N 0.000 description 1
- 206010049171 Pulmonary vein stenosis Diseases 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- 206010049418 Sudden Cardiac Death Diseases 0.000 description 1
- 208000003734 Supraventricular Tachycardia Diseases 0.000 description 1
- 206010049447 Tachyarrhythmia Diseases 0.000 description 1
- 208000001871 Tachycardia Diseases 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 206010047281 Ventricular arrhythmia Diseases 0.000 description 1
- 230000001594 aberrant effect Effects 0.000 description 1
- 238000010317 ablation therapy Methods 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- WYTGDNHDOZPMIW-RCBQFDQVSA-N alstonine Natural products C1=CC2=C3C=CC=CC3=NC2=C2N1C[C@H]1[C@H](C)OC=C(C(=O)OC)[C@H]1C2 WYTGDNHDOZPMIW-RCBQFDQVSA-N 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- IYIKLHRQXLHMJQ-UHFFFAOYSA-N amiodarone Chemical compound CCCCC=1OC2=CC=CC=C2C=1C(=O)C1=CC(I)=C(OCCN(CC)CC)C(I)=C1 IYIKLHRQXLHMJQ-UHFFFAOYSA-N 0.000 description 1
- 229960005260 amiodarone Drugs 0.000 description 1
- 230000037005 anaesthesia Effects 0.000 description 1
- 238000002583 angiography Methods 0.000 description 1
- 230000010100 anticoagulation Effects 0.000 description 1
- 210000000709 aorta Anatomy 0.000 description 1
- 210000001765 aortic valve Anatomy 0.000 description 1
- 230000003126 arrythmogenic effect Effects 0.000 description 1
- 230000002567 autonomic effect Effects 0.000 description 1
- 230000008033 biological extinction Effects 0.000 description 1
- 230000002051 biphasic effect Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000003990 capacitor Substances 0.000 description 1
- 238000013184 cardiac magnetic resonance imaging Methods 0.000 description 1
- 210000004413 cardiac myocyte Anatomy 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 230000020411 cell activation Effects 0.000 description 1
- 230000036978 cell physiology Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 238000000546 chi-square test Methods 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 230000001427 coherent effect Effects 0.000 description 1
- 238000004891 communication Methods 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000001186 cumulative effect Effects 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007850 degeneration Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 238000002592 echocardiography Methods 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 238000013195 electrical cardioversion Methods 0.000 description 1
- 230000009177 electrical depolarization Effects 0.000 description 1
- 230000005672 electromagnetic field Effects 0.000 description 1
- 238000009713 electroplating Methods 0.000 description 1
- 210000002889 endothelial cell Anatomy 0.000 description 1
- 210000003038 endothelium Anatomy 0.000 description 1
- 210000001723 extracellular space Anatomy 0.000 description 1
- 210000000887 face Anatomy 0.000 description 1
- 238000011010 flushing procedure Methods 0.000 description 1
- 238000009499 grossing Methods 0.000 description 1
- 210000003709 heart valve Anatomy 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000003116 impacting effect Effects 0.000 description 1
- 238000010874 in vitro model Methods 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 229960002725 isoflurane Drugs 0.000 description 1
- 238000005304 joining Methods 0.000 description 1
- 238000012417 linear regression Methods 0.000 description 1
- 238000007477 logistic regression Methods 0.000 description 1
- 210000005244 lower chamber Anatomy 0.000 description 1
- 230000017813 membrane repolarization Effects 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 238000010197 meta-analysis Methods 0.000 description 1
- 210000004975 mitral orifice Anatomy 0.000 description 1
- 230000000877 morphologic effect Effects 0.000 description 1
- 210000000107 myocyte Anatomy 0.000 description 1
- 210000001087 myotubule Anatomy 0.000 description 1
- HLXZNVUGXRDIFK-UHFFFAOYSA-N nickel titanium Chemical compound [Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni] HLXZNVUGXRDIFK-UHFFFAOYSA-N 0.000 description 1
- 229910001000 nickel titanium Inorganic materials 0.000 description 1
- 238000005312 nonlinear dynamic Methods 0.000 description 1
- 230000001314 paroxysmal effect Effects 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 230000001991 pathophysiological effect Effects 0.000 description 1
- 238000003909 pattern recognition Methods 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 230000010363 phase shift Effects 0.000 description 1
- 239000004926 polymethyl methacrylate Substances 0.000 description 1
- 238000005381 potential energy Methods 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000001536 pro-arrhythmogenic effect Effects 0.000 description 1
- 208000037821 progressive disease Diseases 0.000 description 1
- 210000001147 pulmonary artery Anatomy 0.000 description 1
- 230000002685 pulmonary effect Effects 0.000 description 1
- 210000003102 pulmonary valve Anatomy 0.000 description 1
- 238000007674 radiofrequency ablation Methods 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000002336 repolarization Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 210000001525 retina Anatomy 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 238000002922 simulated annealing Methods 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 230000007480 spreading Effects 0.000 description 1
- 238000003892 spreading Methods 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 230000000153 supplemental effect Effects 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 230000002459 sustained effect Effects 0.000 description 1
- 230000009897 systematic effect Effects 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 230000008685 targeting Effects 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- AWLILQARPMWUHA-UHFFFAOYSA-M thiopental sodium Chemical compound [Na+].CCCC(C)C1(CC)C(=O)NC([S-])=NC1=O AWLILQARPMWUHA-UHFFFAOYSA-M 0.000 description 1
- 230000007838 tissue remodeling Effects 0.000 description 1
- 238000010937 topological data analysis Methods 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- 238000011269 treatment regimen Methods 0.000 description 1
- 238000009827 uniform distribution Methods 0.000 description 1
- 238000012762 unpaired Student’s t-test Methods 0.000 description 1
- 210000001186 vagus nerve Anatomy 0.000 description 1
- 238000010200 validation analysis Methods 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 210000005166 vasculature Anatomy 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 238000011179 visual inspection Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/68—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
- A61B5/6846—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be brought in contact with an internal body part, i.e. invasive
- A61B5/6847—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be brought in contact with an internal body part, i.e. invasive mounted on an invasive device
- A61B5/6852—Catheters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/24—Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
- A61B5/25—Bioelectric electrodes therefor
- A61B5/279—Bioelectric electrodes therefor specially adapted for particular uses
- A61B5/28—Bioelectric electrodes therefor specially adapted for particular uses for electrocardiography [ECG]
- A61B5/283—Invasive
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/24—Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
- A61B5/316—Modalities, i.e. specific diagnostic methods
- A61B5/318—Heart-related electrical modalities, e.g. electrocardiography [ECG]
- A61B5/346—Analysis of electrocardiograms
- A61B5/349—Detecting specific parameters of the electrocardiograph cycle
- A61B5/361—Detecting fibrillation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/02—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by cooling, e.g. cryogenic techniques
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B2017/00017—Electrical control of surgical instruments
- A61B2017/00022—Sensing or detecting at the treatment site
- A61B2017/00039—Electric or electromagnetic phenomena other than conductivity, e.g. capacity, inductivity, Hall effect
- A61B2017/00044—Sensing electrocardiography, i.e. ECG
- A61B2017/00048—Spectral analysis
- A61B2017/00053—Mapping
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00315—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body for treatment of particular body parts
- A61B2018/00345—Vascular system
- A61B2018/00351—Heart
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00571—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body for achieving a particular surgical effect
- A61B2018/00577—Ablation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00636—Sensing and controlling the application of energy
- A61B2018/00642—Sensing and controlling the application of energy with feedback, i.e. closed loop control
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00636—Sensing and controlling the application of energy
- A61B2018/00696—Controlled or regulated parameters
- A61B2018/00702—Power or energy
- A61B2018/00708—Power or energy switching the power on or off
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00636—Sensing and controlling the application of energy
- A61B2018/00773—Sensed parameters
- A61B2018/00839—Bioelectrical parameters, e.g. ECG, EEG
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00636—Sensing and controlling the application of energy
- A61B2018/00898—Alarms or notifications created in response to an abnormal condition
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00636—Sensing and controlling the application of energy
- A61B2018/00904—Automatic detection of target tissue
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Surgery (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Medical Informatics (AREA)
- Molecular Biology (AREA)
- Physics & Mathematics (AREA)
- Cardiology (AREA)
- Biophysics (AREA)
- Pathology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Otolaryngology (AREA)
- Plasma & Fusion (AREA)
- Measurement And Recording Of Electrical Phenomena And Electrical Characteristics Of The Living Body (AREA)
- Surgical Instruments (AREA)
- Materials For Medical Uses (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US15/369,483 US10912476B2 (en) | 2013-01-16 | 2016-12-05 | Catheters, systems, and related methods for mapping, minimizing, and treating cardiac fibrillation |
| PCT/US2017/063747 WO2018106496A1 (en) | 2016-12-05 | 2017-11-29 | Catheters, systems, and related methods for mapping, minimizing, and treating cardiac fibrillation |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| IL267047A IL267047A (en) | 2019-08-29 |
| IL267047B IL267047B (en) | 2022-10-01 |
| IL267047B2 true IL267047B2 (en) | 2023-02-01 |
Family
ID=62491310
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL267047A IL267047B2 (en) | 2016-12-05 | 2019-06-03 | Catheters, systems and related methods for mapping, minimizing and treating cardiac fibrillation |
Country Status (5)
| Country | Link |
|---|---|
| EP (1) | EP3547910A4 (de) |
| AU (1) | AU2017370535B2 (de) |
| CA (1) | CA3045988A1 (de) |
| IL (1) | IL267047B2 (de) |
| WO (1) | WO2018106496A1 (de) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3340916B1 (de) | 2015-10-21 | 2020-12-02 | St. Jude Medical, Cardiology Division, Inc. | Hochdichter elektrodenmapping-katheter |
| US11844616B2 (en) | 2019-08-13 | 2023-12-19 | Biosense Webster (Israel) Ltd. | Enhanced visualization of organ electrical activity |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20160045123A1 (en) * | 2014-08-12 | 2016-02-18 | Biosense Webster (Israel) Ltd. | Line of block detection |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6243603B1 (en) * | 1998-09-15 | 2001-06-05 | Uab Research Foundation | Methods and apparatus for detecting medical conditions of the heart |
| ATE506891T1 (de) * | 2002-08-24 | 2011-05-15 | St Jude Medical Atrial Fibrill | Verfahren und gerät zur lokalisierung der fossa ovalis und durchführung einer transseptalen punktion |
| US8880158B2 (en) * | 2013-01-16 | 2014-11-04 | University Of Vermont | Methods and systems for determining spatiotemporal variability for mapping cardiac fibrillation |
| US10912476B2 (en) * | 2013-01-16 | 2021-02-09 | University Of Vermont | Catheters, systems, and related methods for mapping, minimizing, and treating cardiac fibrillation |
-
2017
- 2017-11-29 AU AU2017370535A patent/AU2017370535B2/en active Active
- 2017-11-29 WO PCT/US2017/063747 patent/WO2018106496A1/en active Application Filing
- 2017-11-29 EP EP17879048.1A patent/EP3547910A4/de not_active Ceased
- 2017-11-29 CA CA3045988A patent/CA3045988A1/en active Pending
-
2019
- 2019-06-03 IL IL267047A patent/IL267047B2/en unknown
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20160045123A1 (en) * | 2014-08-12 | 2016-02-18 | Biosense Webster (Israel) Ltd. | Line of block detection |
Also Published As
| Publication number | Publication date |
|---|---|
| EP3547910A4 (de) | 2020-07-15 |
| CA3045988A1 (en) | 2018-06-14 |
| IL267047A (en) | 2019-08-29 |
| EP3547910A1 (de) | 2019-10-09 |
| AU2017370535B2 (en) | 2023-06-29 |
| WO2018106496A1 (en) | 2018-06-14 |
| AU2017370535A1 (en) | 2019-07-04 |
| IL267047B (en) | 2022-10-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20220015678A1 (en) | Catheters, systems, and related methods for mapping, minimizing, and treating cardiac fibrillation | |
| AU2019204963B2 (en) | Systems, catheters, and related methods for mapping, minimizing, and treating cardiac fibrillation | |
| US20230329620A1 (en) | Methods and systems for wavelength mapping cardiac fibrillation and optimizing ablation lesion placement | |
| Benharash et al. | Quantitative analysis of localized sources identified by focal impulse and rotor modulation mapping in atrial fibrillation | |
| De Bakker et al. | The pathophysiologic basis of fractionated and complex electrograms and the impact of recording techniques on their detection and interpretation | |
| Narayan et al. | Treatment of atrial fibrillation by the ablation of localized sources: CONFIRM (Conventional Ablation for Atrial Fibrillation With or Without Focal Impulse and Rotor Modulation) trial | |
| Sapp et al. | Inverse solution mapping of epicardial potentials: quantitative comparison with epicardial contact mapping | |
| Kalifa et al. | Mechanisms of wave fractionation at boundaries of high-frequency excitation in the posterior left atrium of the isolated sheep heart during atrial fibrillation | |
| Lin et al. | Frequency analysis in different types of paroxysmal atrial fibrillation | |
| Daoud et al. | Identification of repetitive activation patterns using novel computational analysis of multielectrode recordings during atrial fibrillation and flutter in humans | |
| IL275975A (en) | Mapping of ascending fibrillation | |
| EP3886694A1 (de) | Verfahren und systeme zur wellenlängenkartierung von herzflimmern und zur optimierung der platzierung von ablationsläsionen | |
| IL267047B2 (en) | Catheters, systems and related methods for mapping, minimizing and treating cardiac fibrillation | |
| Guillem et al. | Noninvasive identification of atrial fibrillation drivers: Simulation and patient data evaluation | |
| Vila | Atrial Complex Networks in Endocavitary Recordings During Atrial Fibrillation |